Alegado, Jeicel C.

HRN: 23-12-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
AMPICILLIN 500MG (VIAL)
05/29/2023
06/04/2023
IV
140mg
Q6
Tc Cellulitis
Checking Final Appropriateness 
05/31/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/31/2023
06/06/2023
IV
55mg
Q8Hrs
Sepsis
Waiting Final Action 
05/31/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/31/2023
06/06/2023
IV
275mg
Q6Hrs
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: